NIH-funded research R37 grant

How breast cancer cells affect the brain environment for metastasis

Official title: PDGF-BB and the metastatic brain microenvironment

Funded at Ohio State University · NIH-10906359 · Data updated 2026-11-12

This study is looking at how a protein made by breast cancer cells affects the brain and helps the cancer spread, and it aims to find out if blocking this protein can lead to new treatments for people with breast cancer that has spread to the brain.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startAugust 11, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$440,127
NIH project number5R37CA282660-02
Project IDNIH-10906359 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with breast cancer, particularly those at risk of developing brain metastases.

Less likely to help

Patients with breast cancer that has not metastasized or those with other types of cancer may not benefit from this research.

What this research studies

This research investigates the role of a specific protein, PDGF-BB, produced by breast cancer cells in influencing the brain's environment to promote cancer spread. It aims to understand how this protein interacts with various cell types in the brain, potentially leading to changes that support tumor growth. The study will utilize mouse models to explore the effects of inhibiting this protein on tumor development in the brain, providing insights into new treatment strategies for patients with breast cancer that has spread to the brain.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent or reduce breast cancer metastasis to the brain.

How similar studies have gone: Previous research has shown promising results in targeting similar pathways in cancer treatment, indicating potential for success in this approach.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Sizemore, Gina Marie — Ohio State University
  • Study coordinator: Sizemore, Gina Marie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.